Comparing overall survival of patients with metastatic uveal melanoma by sequence of Tebentafusp versus combination immune checkpoint inhibitors.

被引：0
|
作者：
Shikdar, Sufana
Day, Silas
Ikeguchi, Alexandra
Ying, Yuan
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[2] Univ Oklahoma, Med Ctr, Oklahoma City, OK USA
[3] Stephenson Canc Ctr, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21505
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Overall Survival in Patients with versus Without Rheumatoid Arthritis Initiating Immune Checkpoint Inhibitors for Metastatic Non Small Cell Lung Cancer
    Jannat-Khah, Deanna
    Curtis, Jeffrey R.
    Xie, Fenglong
    Saxena, Ashish
    Bass, Anne
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1904 - 1906
  • [42] Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients
    Bol, Kalijn F.
    Mensink, Hanneke W.
    Aarntzen, Erik H. J. G.
    Schreibelt, Gerty
    Keunen, Jan E. E.
    Coulie, Pierre G.
    De Klein, Annelies
    Punt, Cornelis J. A.
    Paridaens, Dion
    Figdor, Carl G.
    De Vries, I. Jolanda M.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 158 (05) : 939 - 947
  • [43] Primary resistance to immune-checkpoint inhibitors in patients with metastatic melanoma
    Amaral, Teresa
    Assi, Zeinab
    Keim, Ulrike
    Meiwes, Andreas
    Thomas, Ioannis
    Wilhelmi, Julia
    Eigentler, Thomas
    Garbe, Claus
    Seeber, Olivia
    JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [44] Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study
    Vanaken, Lize
    Woei-A-Jin, F. J. Sherida H.
    Van Ginderdeuren, Rita
    Deroose, Christophe M.
    Laenen, Annouschka
    Missotten, Guy
    Thal, Dietmar R.
    Bechter, Oliver
    Schoffski, Patrick
    Clement, Paul
    ACTA ONCOLOGICA, 2023, 62 (05) : 480 - 487
  • [45] Association of PTPN11 mutation with tumor mutation burden and survival in melanoma patients treated with immune checkpoint inhibitors.
    Long, De
    Fan, Dandan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [46] MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients: A retrospective study.
    Saint-Ghislain, Mathilde
    Geoffrois, Lionnel
    Gastaud, Lauris
    Lesimple, Thierry
    Negrier, Sylvie
    Penel, Nicolas
    Kurtz, Jean Emmanuel
    Le Corre, Yannick
    Dutriaux, Caroline
    Gardrat, Sophie
    Barnhill, Raymond
    Matet, Alexandre
    Cassoux, Nathalie
    Ramtohul, Toulsie
    Servois, Vincent
    Mariani, Pascale
    Piperno-Neumann, Sophie
    Rodrigues, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [47] Use of First-Line Immune Checkpoint Inhibitors and Association With Overall Survival Among Patients With Metastatic Melanoma in the Anti-PD-1 Era
    Lamba, Nayan
    Ott, Patrick A.
    Iorgulescu, J. Bryan
    JAMA NETWORK OPEN, 2022, 5 (08) : E2225459
  • [48] Baseline geriatric 8 (G8) screening tool to predict overall survival in metastatic urothelial carcinoma treated with immune checkpoint inhibitors.
    Rhee, Christopher H.
    Goyal, Subir
    Liu, Yuan
    Martini, Dylan J.
    Nazha, Bassel
    Kucuk, Omer
    Carthon, Bradley Curtis
    Bilen, Mehmet Asim
    Brown, Jacqueline T.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy
    Susan Costantini
    Gabriele Madonna
    Mariaelena Capone
    Elena Di Gennaro
    Palmina Bagnara
    Federica Renza
    Domenico Mallardo
    Roberta Affatato
    Carlo Vitagliano
    Marilena Romanelli
    Marilena Tuffanelli
    Ester Simeone
    Gennaro Ciliberto
    Paolo A. Ascierto
    Alfredo Budillon
    Journal of Experimental & Clinical Cancer Research, 44 (1)
  • [50] New diagnostic index for prediction of severe irAEs in patients with metastatic melanoma taking checkpoint inhibitors.
    Zhukova, Natalia V.
    Orlova, Rashida
    Malkova, Anna
    Kaledina, Ekaterina
    Demchenkova, Alexandra
    Naymushina, Polina
    Nazarov, V.
    Mazing, A.
    Lapin, S.
    Beliak, Natalia P.
    Shoenfeld, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345